Delivery Order SPE2DB20D3101-SPE2DB22FH6B1

Award Date 1/26/22
Potential Completion Date 1/27/22
Potential Value $8.1K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $72,201.60 for the supply of Eliquis 2.5 mg tablets. The award was made by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of September 19, 2023. The contract is a firm-fixed-price delivery order, with no set-aside designation, indicating open competition. Amerisourcebergen is a major pharmaceutical distributor that holds significant...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $8,163.70 for the pharmaceutical product Eliquis 2.5 mg tablets. The award was made by the Defense Logistics Agency (DLA), a defense agency, on March 7, 2023, with a completion date of March 8, 2023. The contract is a firm fixed-price delivery order with no set-aside designation, indicating open competition. Amerisourcebergen is a major pharmaceutical distributor that holds...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $18,654.74. The contract is for the supply of Eliquis 5 mg tablets for the Defense Logistics Agency (DLA), a defense agency. The contract has a completion date of April 3, 2024 and is a firm-fixed-price arrangement. The contract was awarded on April 2, 2024 and was not set aside for any specific business type. Amerisourcebergen Drug Corp is a major pharmaceutical distributor...
This federal contract award was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $15,106.29 Firm Fixed Price Delivery Order is for the pharmaceutical product Eliquis 5 mg tablets. The contract has an ultimate completion date of February 28, 2024. Amerisourcebergen Drug Corp holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Delivery Order valued at $6,993.30 for the supply of Eliquis 5 mg tablets. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of June 5, 2023. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Delivery Order valued at $13,877.40 for the supply of Eliquis 5 mg tablets. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of April 18, 2023. The contract is a Firm Fixed Price agreement with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC)...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $8,878.29 firm fixed-price delivery order is for the pharmaceutical product Eliquis 5 mg Tablet 60s. The contract has an ultimate completion date of April 26, 2024. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that serves as a primary vehicle for providing a...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $4,102.94 for the pharmaceutical product Eliquis 5 mg tablets. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of May 6, 2024. This award is not associated with a set-aside program. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is for the delivery of Eliquis 5 mg tablets to the U.S. government. The $3,969.61 firm fixed-price delivery order was issued by the Defense Logistics Agency (DLA) Troop Support Medical, a Defense agency. Amerisourcebergen holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that serves as the primary vehicle for the company to provide a comprehensive...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is for the delivery of Eliquis 5 mg tablets. The $6,165.69 firm fixed-price delivery order was issued by the Defense Logistics Agency (DLA) on January 6, 2022, with a completion date of January 7, 2022. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that...
  • SPE2DB20D3101
    Indefinite Delivery Contract
  • SPE2DB20D3101-SPE2DB22FH6B1
    Delivery Order

This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a $8,091.91 firm fixed-price delivery order issued by the Defense Logistics Agency (DLA) for the pharmaceutical product Eliquis 5 mg tablet. The contract has an ultimate completion date of January 27, 2022 and does not have a set-aside designation, indicating open competition. Amerisourcebergen is a major pharmaceutical distributor that holds two significant Indefinite Delivery Contracts (IDCs) with the DLA and the Department of Justice Federal Bureau of Investigation, valued at up to $999,999,999.00 and $750,000 respectively, for the provision of a wide range of pharmaceutical products and medical supplies to support various federal healthcare programs, including those serving the military and veterans.

Generated 2/27/25, 11:11 AM